Neurodegenerative diseases represent a significant challenge in medical science, impacting millions globally. Despite advancements in diagnostic technology, ...

Lorem, a nonprofit foundation, today announced that nine patients with an ultra-rare type of amyotrophic lateral sclerosis (ALS) have been treated during the first year of a multi-year grant from the ...

Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her ...

ALS Canada has named 39 Canadians to receive the King Charles III Coronation Medal for their efforts into research and advocacy for ALS.

Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...

Four serum neurofilament light chain tests show high accuracy in diagnosing ALS and predicting its progression, new research suggests.

Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investorsFinancing extends Arbor’s cash ...

A study indicates ALS Functional Rating Scale-Revised self-assessments using a smartphone app were as reliable as those done ...

Cognixion's Axon-R headset is a device designed to read brain activity using EEG as a direct input for controls. Using brain ...

Researchers have revealed that vascular dysfunction can contribute to neurodegenerative diseases including Alzheimer's and ...

Researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like Alzheimer's disease and amyotrophic lateral sclerosis ...

Neurizon Therapeutics has submitted a formal request to the US Food and Drug Administration (FDA) for clarification on two ...